Needle-free Injection Systems Industry Research Report 2023
Number of Pages: 100
Category: Medical Devices & Consumables
Country: Tibet
Format:
Published Date: 08 Aug 2023
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Highlights
The global Needle-free Injection Systems market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Needle-free Injection Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-free Injection Systems.
The Needle-free Injection Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Needle-free Injection Systems market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-free Injection Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
DAntonio Consultants International
Lepu Medical
TECHiJET
Product Type Insights
Global markets are presented by Needle-free Injection Systems type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Needle-free Injection Systems are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Needle-free Injection Systems segment by Power
Reusable Injector
Single-use Injector
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Needle-free Injection Systems market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Needle-free Injection Systems market.
Needle-free Injection Systems segment by Application
Vaccine Delivery
Insulin Delivery
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Needle-free Injection Systems market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Injection Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Needle-free Injection Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Needle-free Injection Systems industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Injection Systems.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Needle-free Injection Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Needle-free Injection Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Needle-free Injection Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by power, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Highlights
The global Needle-free Injection Systems market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Needle-free Injection Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-free Injection Systems.
The Needle-free Injection Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Needle-free Injection Systems market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-free Injection Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
DAntonio Consultants International
Lepu Medical
TECHiJET
Product Type Insights
Global markets are presented by Needle-free Injection Systems type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Needle-free Injection Systems are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Needle-free Injection Systems segment by Power
Reusable Injector
Single-use Injector
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Needle-free Injection Systems market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Needle-free Injection Systems market.
Needle-free Injection Systems segment by Application
Vaccine Delivery
Insulin Delivery
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Needle-free Injection Systems market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Needle-free Injection Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Needle-free Injection Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Needle-free Injection Systems industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Needle-free Injection Systems.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Needle-free Injection Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Needle-free Injection Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Needle-free Injection Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by power, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Needle-free Injection Systems Market Size (2018-2029) & (US$ Million)
2.2.2 Global Needle-free Injection Systems Sales (2018-2029)
2.2.3 Global Needle-free Injection Systems Market Average Price (2018-2029)
2.3 Needle-free Injection Systems by Power
2.3.1 Market Value Comparison by Power (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Reusable Injector
1.2.3 Single-use Injector
2.4 Needle-free Injection Systems by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Vaccine Delivery
2.4.3 Insulin Delivery
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Needle-free Injection Systems Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Needle-free Injection Systems Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Needle-free Injection Systems Revenue of Manufacturers (2018-2023)
3.4 Global Needle-free Injection Systems Average Price by Manufacturers (2018-2023)
3.5 Global Needle-free Injection Systems Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Needle-free Injection Systems, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Needle-free Injection Systems, Product Type & Application
3.8 Global Manufacturers of Needle-free Injection Systems, Date of Enter into This Industry
3.9 Global Needle-free Injection Systems Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Antares Pharma
4.1.1 Antares Pharma Company Information
4.1.2 Antares Pharma Business Overview
4.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Antares Pharma Needle-free Injection Systems Product Portfolio
4.1.5 Antares Pharma Recent Developments
4.2 Endo International plc
4.2.1 Endo International plc Company Information
4.2.2 Endo International plc Business Overview
4.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Endo International plc Needle-free Injection Systems Product Portfolio
4.2.5 Endo International plc Recent Developments
4.3 Inovio Pharmaceuticals
4.3.1 Inovio Pharmaceuticals Company Information
4.3.2 Inovio Pharmaceuticals Business Overview
4.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolio
4.3.5 Inovio Pharmaceuticals Recent Developments
4.4 Injex Pharma
4.4.1 Injex Pharma Company Information
4.4.2 Injex Pharma Business Overview
4.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Injex Pharma Needle-free Injection Systems Product Portfolio
4.4.5 Injex Pharma Recent Developments
4.5 National Medical Products Inc (J-Tip)
4.5.1 National Medical Products Inc (J-Tip) Company Information
4.5.2 National Medical Products Inc (J-Tip) Business Overview
4.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolio
6.5.5 National Medical Products Inc (J-Tip) Recent Developments
4.6 Recipharm
4.6.1 Recipharm Company Information
4.6.2 Recipharm Business Overview
4.6.3 Recipharm Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Recipharm Needle-free Injection Systems Product Portfolio
4.6.5 Recipharm Recent Developments
4.7 European Pharma Group (InsuJet)
4.7.1 European Pharma Group (InsuJet) Company Information
4.7.2 European Pharma Group (InsuJet) Business Overview
4.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolio
4.7.5 European Pharma Group (InsuJet) Recent Developments
6.8 Miracle Medical
4.8.1 Miracle Medical Company Information
4.8.2 Miracle Medical Business Overview
4.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Miracle Medical Needle-free Injection Systems Product Portfolio
4.8.5 Miracle Medical Recent Developments
4.9 Medical International Technology (MIT)
4.9.1 Medical International Technology (MIT) Company Information
4.9.2 Medical International Technology (MIT) Business Overview
4.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolio
4.9.5 Medical International Technology (MIT) Recent Developments
4.10 Akra Dermojet
4.10.1 Akra Dermojet Company Information
4.10.2 Akra Dermojet Business Overview
4.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Akra Dermojet Needle-free Injection Systems Product Portfolio
4.10.5 Akra Dermojet Recent Developments
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Needle-free Injection Systems Business Overview
6.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.11.4 PharmaJet Needle-free Injection Systems Product Portfolio
6.11.5 PharmaJet Recent Developments
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Needle-free Injection Systems Business Overview
6.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Portal Instruments Needle-free Injection Systems Product Portfolio
6.12.5 Portal Instruments Recent Developments
6.13 Crossject Medical Technology
6.13.1 Crossject Medical Technology Company Information
6.13.2 Crossject Medical Technology Needle-free Injection Systems Business Overview
6.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Crossject Medical Technology Needle-free Injection Systems Product Portfolio
6.13.5 Crossject Medical Technology Recent Developments
6.14 MIKA MEDICAL
6.14.1 MIKA MEDICAL Company Information
6.14.2 MIKA MEDICAL Needle-free Injection Systems Business Overview
6.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MIKA MEDICAL Needle-free Injection Systems Product Portfolio
6.14.5 MIKA MEDICAL Recent Developments
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments
6.16 DAntonio Consultants International
6.16.1 DAntonio Consultants International Company Information
6.16.2 DAntonio Consultants International Needle-free Injection Systems Business Overview
6.16.3 DAntonio Consultants International Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.16.4 DAntonio Consultants International Needle-free Injection Systems Product Portfolio
6.16.5 DAntonio Consultants International Recent Developments
6.17 Lepu Medical
6.17.1 Lepu Medical Company Information
6.17.2 Lepu Medical Needle-free Injection Systems Business Overview
6.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Lepu Medical Needle-free Injection Systems Product Portfolio
6.17.5 Lepu Medical Recent Developments
6.18 TECHiJET
6.18.1 TECHiJET Company Information
6.18.2 TECHiJET Needle-free Injection Systems Business Overview
6.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.18.4 TECHiJET Needle-free Injection Systems Product Portfolio
6.18.5 TECHiJET Recent Developments
5 Global Needle-free Injection Systems Market Scenario by Region
5.1 Global Needle-free Injection Systems Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Needle-free Injection Systems Sales by Region: 2018-2029
5.2.1 Global Needle-free Injection Systems Sales by Region: 2018-2023
5.2.2 Global Needle-free Injection Systems Sales by Region: 2024-2029
5.3 Global Needle-free Injection Systems Revenue by Region: 2018-2029
5.3.1 Global Needle-free Injection Systems Revenue by Region: 2018-2023
5.3.2 Global Needle-free Injection Systems Revenue by Region: 2024-2029
5.4 North America Needle-free Injection Systems Market Facts & Figures by Country
5.4.1 North America Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Needle-free Injection Systems Sales by Country (2018-2029)
5.4.3 North America Needle-free Injection Systems Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Needle-free Injection Systems Market Facts & Figures by Country
5.5.1 Europe Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Needle-free Injection Systems Sales by Country (2018-2029)
5.5.3 Europe Needle-free Injection Systems Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Needle-free Injection Systems Market Facts & Figures by Country
5.6.1 Asia Pacific Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Needle-free Injection Systems Sales by Country (2018-2029)
5.6.3 Asia Pacific Needle-free Injection Systems Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Needle-free Injection Systems Market Facts & Figures by Country
5.7.1 Latin America Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Needle-free Injection Systems Sales by Country (2018-2029)
5.7.3 Latin America Needle-free Injection Systems Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Needle-free Injection Systems Market Facts & Figures by Country
5.8.1 Middle East and Africa Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Needle-free Injection Systems Sales by Country (2018-2029)
5.8.3 Middle East and Africa Needle-free Injection Systems Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Power
6.1 Global Needle-free Injection Systems Sales by Power (2018-2029)
6.1.1 Global Needle-free Injection Systems Sales by Power (2018-2029) & (K Units)
6.1.2 Global Needle-free Injection Systems Sales Market Share by Power (2018-2029)
6.2 Global Needle-free Injection Systems Revenue by Power (2018-2029)
6.2.1 Global Needle-free Injection Systems Sales by Power (2018-2029) & (US$ Million)
6.2.2 Global Needle-free Injection Systems Revenue Market Share by Power (2018-2029)
6.3 Global Needle-free Injection Systems Price by Power (2018-2029)
7 Segment by Application
7.1 Global Needle-free Injection Systems Sales by Application (2018-2029)
7.1.1 Global Needle-free Injection Systems Sales by Application (2018-2029) & (K Units)
7.1.2 Global Needle-free Injection Systems Sales Market Share by Application (2018-2029)
7.2 Global Needle-free Injection Systems Revenue by Application (2018-2029)
6.2.1 Global Needle-free Injection Systems Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Needle-free Injection Systems Revenue Market Share by Application (2018-2029)
7.3 Global Needle-free Injection Systems Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Needle-free Injection Systems Value Chain Analysis
8.1.1 Needle-free Injection Systems Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Needle-free Injection Systems Production Mode & Process
8.2 Needle-free Injection Systems Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Needle-free Injection Systems Distributors
8.2.3 Needle-free Injection Systems Customers
9 Global Needle-free Injection Systems Analyzing Market Dynamics
9.1 Needle-free Injection Systems Industry Trends
9.2 Needle-free Injection Systems Industry Drivers
9.3 Needle-free Injection Systems Industry Opportunities and Challenges
9.4 Needle-free Injection Systems Industry Restraints
10 Report Conclusion
11 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Needle-free Injection Systems Market Size (2018-2029) & (US$ Million)
2.2.2 Global Needle-free Injection Systems Sales (2018-2029)
2.2.3 Global Needle-free Injection Systems Market Average Price (2018-2029)
2.3 Needle-free Injection Systems by Power
2.3.1 Market Value Comparison by Power (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Reusable Injector
1.2.3 Single-use Injector
2.4 Needle-free Injection Systems by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Vaccine Delivery
2.4.3 Insulin Delivery
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Needle-free Injection Systems Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Needle-free Injection Systems Sales (K Units) of Manufacturers (2018-2023)
3.3 Global Needle-free Injection Systems Revenue of Manufacturers (2018-2023)
3.4 Global Needle-free Injection Systems Average Price by Manufacturers (2018-2023)
3.5 Global Needle-free Injection Systems Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Needle-free Injection Systems, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Needle-free Injection Systems, Product Type & Application
3.8 Global Manufacturers of Needle-free Injection Systems, Date of Enter into This Industry
3.9 Global Needle-free Injection Systems Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Antares Pharma
4.1.1 Antares Pharma Company Information
4.1.2 Antares Pharma Business Overview
4.1.3 Antares Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Antares Pharma Needle-free Injection Systems Product Portfolio
4.1.5 Antares Pharma Recent Developments
4.2 Endo International plc
4.2.1 Endo International plc Company Information
4.2.2 Endo International plc Business Overview
4.2.3 Endo International plc Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Endo International plc Needle-free Injection Systems Product Portfolio
4.2.5 Endo International plc Recent Developments
4.3 Inovio Pharmaceuticals
4.3.1 Inovio Pharmaceuticals Company Information
4.3.2 Inovio Pharmaceuticals Business Overview
4.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Product Portfolio
4.3.5 Inovio Pharmaceuticals Recent Developments
4.4 Injex Pharma
4.4.1 Injex Pharma Company Information
4.4.2 Injex Pharma Business Overview
4.4.3 Injex Pharma Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Injex Pharma Needle-free Injection Systems Product Portfolio
4.4.5 Injex Pharma Recent Developments
4.5 National Medical Products Inc (J-Tip)
4.5.1 National Medical Products Inc (J-Tip) Company Information
4.5.2 National Medical Products Inc (J-Tip) Business Overview
4.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product Portfolio
6.5.5 National Medical Products Inc (J-Tip) Recent Developments
4.6 Recipharm
4.6.1 Recipharm Company Information
4.6.2 Recipharm Business Overview
4.6.3 Recipharm Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Recipharm Needle-free Injection Systems Product Portfolio
4.6.5 Recipharm Recent Developments
4.7 European Pharma Group (InsuJet)
4.7.1 European Pharma Group (InsuJet) Company Information
4.7.2 European Pharma Group (InsuJet) Business Overview
4.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Product Portfolio
4.7.5 European Pharma Group (InsuJet) Recent Developments
6.8 Miracle Medical
4.8.1 Miracle Medical Company Information
4.8.2 Miracle Medical Business Overview
4.8.3 Miracle Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Miracle Medical Needle-free Injection Systems Product Portfolio
4.8.5 Miracle Medical Recent Developments
4.9 Medical International Technology (MIT)
4.9.1 Medical International Technology (MIT) Company Information
4.9.2 Medical International Technology (MIT) Business Overview
4.9.3 Medical International Technology (MIT) Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Medical International Technology (MIT) Needle-free Injection Systems Product Portfolio
4.9.5 Medical International Technology (MIT) Recent Developments
4.10 Akra Dermojet
4.10.1 Akra Dermojet Company Information
4.10.2 Akra Dermojet Business Overview
4.10.3 Akra Dermojet Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Akra Dermojet Needle-free Injection Systems Product Portfolio
4.10.5 Akra Dermojet Recent Developments
6.11 PharmaJet
6.11.1 PharmaJet Company Information
6.11.2 PharmaJet Needle-free Injection Systems Business Overview
6.11.3 PharmaJet Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.11.4 PharmaJet Needle-free Injection Systems Product Portfolio
6.11.5 PharmaJet Recent Developments
6.12 Portal Instruments
6.12.1 Portal Instruments Company Information
6.12.2 Portal Instruments Needle-free Injection Systems Business Overview
6.12.3 Portal Instruments Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Portal Instruments Needle-free Injection Systems Product Portfolio
6.12.5 Portal Instruments Recent Developments
6.13 Crossject Medical Technology
6.13.1 Crossject Medical Technology Company Information
6.13.2 Crossject Medical Technology Needle-free Injection Systems Business Overview
6.13.3 Crossject Medical Technology Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Crossject Medical Technology Needle-free Injection Systems Product Portfolio
6.13.5 Crossject Medical Technology Recent Developments
6.14 MIKA MEDICAL
6.14.1 MIKA MEDICAL Company Information
6.14.2 MIKA MEDICAL Needle-free Injection Systems Business Overview
6.14.3 MIKA MEDICAL Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MIKA MEDICAL Needle-free Injection Systems Product Portfolio
6.14.5 MIKA MEDICAL Recent Developments
6.15 Ferring Pharmaceuticals
6.15.1 Ferring Pharmaceuticals Company Information
6.15.2 Ferring Pharmaceuticals Needle-free Injection Systems Business Overview
6.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Product Portfolio
6.15.5 Ferring Pharmaceuticals Recent Developments
6.16 DAntonio Consultants International
6.16.1 DAntonio Consultants International Company Information
6.16.2 DAntonio Consultants International Needle-free Injection Systems Business Overview
6.16.3 DAntonio Consultants International Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.16.4 DAntonio Consultants International Needle-free Injection Systems Product Portfolio
6.16.5 DAntonio Consultants International Recent Developments
6.17 Lepu Medical
6.17.1 Lepu Medical Company Information
6.17.2 Lepu Medical Needle-free Injection Systems Business Overview
6.17.3 Lepu Medical Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Lepu Medical Needle-free Injection Systems Product Portfolio
6.17.5 Lepu Medical Recent Developments
6.18 TECHiJET
6.18.1 TECHiJET Company Information
6.18.2 TECHiJET Needle-free Injection Systems Business Overview
6.18.3 TECHiJET Needle-free Injection Systems Sales, Revenue and Gross Margin (2018-2023)
6.18.4 TECHiJET Needle-free Injection Systems Product Portfolio
6.18.5 TECHiJET Recent Developments
5 Global Needle-free Injection Systems Market Scenario by Region
5.1 Global Needle-free Injection Systems Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Needle-free Injection Systems Sales by Region: 2018-2029
5.2.1 Global Needle-free Injection Systems Sales by Region: 2018-2023
5.2.2 Global Needle-free Injection Systems Sales by Region: 2024-2029
5.3 Global Needle-free Injection Systems Revenue by Region: 2018-2029
5.3.1 Global Needle-free Injection Systems Revenue by Region: 2018-2023
5.3.2 Global Needle-free Injection Systems Revenue by Region: 2024-2029
5.4 North America Needle-free Injection Systems Market Facts & Figures by Country
5.4.1 North America Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Needle-free Injection Systems Sales by Country (2018-2029)
5.4.3 North America Needle-free Injection Systems Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Needle-free Injection Systems Market Facts & Figures by Country
5.5.1 Europe Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Needle-free Injection Systems Sales by Country (2018-2029)
5.5.3 Europe Needle-free Injection Systems Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Needle-free Injection Systems Market Facts & Figures by Country
5.6.1 Asia Pacific Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Needle-free Injection Systems Sales by Country (2018-2029)
5.6.3 Asia Pacific Needle-free Injection Systems Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Needle-free Injection Systems Market Facts & Figures by Country
5.7.1 Latin America Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Needle-free Injection Systems Sales by Country (2018-2029)
5.7.3 Latin America Needle-free Injection Systems Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Needle-free Injection Systems Market Facts & Figures by Country
5.8.1 Middle East and Africa Needle-free Injection Systems Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Needle-free Injection Systems Sales by Country (2018-2029)
5.8.3 Middle East and Africa Needle-free Injection Systems Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Power
6.1 Global Needle-free Injection Systems Sales by Power (2018-2029)
6.1.1 Global Needle-free Injection Systems Sales by Power (2018-2029) & (K Units)
6.1.2 Global Needle-free Injection Systems Sales Market Share by Power (2018-2029)
6.2 Global Needle-free Injection Systems Revenue by Power (2018-2029)
6.2.1 Global Needle-free Injection Systems Sales by Power (2018-2029) & (US$ Million)
6.2.2 Global Needle-free Injection Systems Revenue Market Share by Power (2018-2029)
6.3 Global Needle-free Injection Systems Price by Power (2018-2029)
7 Segment by Application
7.1 Global Needle-free Injection Systems Sales by Application (2018-2029)
7.1.1 Global Needle-free Injection Systems Sales by Application (2018-2029) & (K Units)
7.1.2 Global Needle-free Injection Systems Sales Market Share by Application (2018-2029)
7.2 Global Needle-free Injection Systems Revenue by Application (2018-2029)
6.2.1 Global Needle-free Injection Systems Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Needle-free Injection Systems Revenue Market Share by Application (2018-2029)
7.3 Global Needle-free Injection Systems Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Needle-free Injection Systems Value Chain Analysis
8.1.1 Needle-free Injection Systems Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Needle-free Injection Systems Production Mode & Process
8.2 Needle-free Injection Systems Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Needle-free Injection Systems Distributors
8.2.3 Needle-free Injection Systems Customers
9 Global Needle-free Injection Systems Analyzing Market Dynamics
9.1 Needle-free Injection Systems Industry Trends
9.2 Needle-free Injection Systems Industry Drivers
9.3 Needle-free Injection Systems Industry Opportunities and Challenges
9.4 Needle-free Injection Systems Industry Restraints
10 Report Conclusion
11 Disclaimer